查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1609835

2024-2032 年日本女性健康市场报告（按年龄组别类型、应用、配销通路和地区）

Japan Women's Health Market Report by Age Group Type, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2023 年，日本女性IMARC Group市场规模达到 24.19 亿美元。机器人辅助手术、微创手术和远距医疗等医疗技术的不断进步，改善了针对女性健康状况的诊断和治疗选择，这主要推动了市场的发展。

女性健康是指女性一生中独特的身体、心理和情绪健康。它涵盖了广泛的问题，包括生殖健康、性健康和整体身体健康。妇女健康的关键面向包括经期和更年期健康、怀孕和分娩、避孕、乳房健康和妇科护理。定期检查、筛检和获得医疗保健对于维持女性健康至关重要。这包括子宫颈抹片检查、乳房X光检查和有关计划生育的讨论。心理健康也至关重要，因为女性更容易受到忧郁和焦虑等疾病的影响。健康的生活方式，包括均衡饮食、规律运动和压力管理，对女性健康起着重要作用。此外，促进性别平等并解决影响妇女健康的社会因素，例如歧视和获得医疗保健的机会不平等，是确保妇女过上健康和充实生活的重要步骤。妇女健康是公共卫生的一个多面向且重要的方面，值得关注和支持。

日本女性保健市场趋势：

日本的女性健康市场是多方面且相互关联的，受到共同塑造女性医疗保健格局的各种因素的推动。首先，医学研究和技术的进步极大地推动了女性健康市场的发展。乳房X光检查和基因检测等诊断工具的突破增强了乳癌和遗传性疾病等疾病的早期发现，改善了整体健康。其次，对女性独特医疗保健需求的认识不断增强发挥了关键作用。妇女越来越了解预防保健的重要性，导致对妇科服务、避孕药和产妇照护的需求更高。此外，社会变化，包括延迟生育和女性人口老化，也促进了该市场的扩张。这些转变需要量身订做的医疗保健解决方案，推动女性健康服务的创新和投资。此外，各种监管变化和政府措施透过多项政策改善了医疗保健的可近性，从而提高了妇女保健服务的可负担性和可近性。预计这将在预测期内推动日本女性健康市场的发展。

日本女性健康市场细分：

年龄组类型见解：

50岁以上

  • 停经后骨质疏鬆症
  • 子宫内膜异位症和子宫肌瘤
  • 停经
  • 其他的

应用见解：

  • 避孕药具
  • 骨质疏鬆症
  • 停经
  • 不孕症
  • 其他的

配销通路见解：

  • 医院药房
  • 零售药局
  • 网路药局

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 到目前为止，日本女性保健市场的表现如何，未来几年将如何表现？
  • COVID-19 对日本女性保健市场有何影响？
  • 日本女性保健市场以年龄层类型划分是怎样的？
  • 日本女性保健市场的应用基础如何细分？
  • 日本女性保健品市场在配销通路上的分化是怎么样的？
  • 日本女性保健市场价值链的各个阶段是什么？
  • 日本女性健康的关键驱动因素和挑战是什么？
  • 日本女性保健市场的结构如何？
  • 日本女性保健品市场的竞争程度如何？

本报告回答的关键问题：

  • 到目前为止，日本女性保健市场的表现如何，未来几年将如何表现？
  • COVID-19 对日本女性保健市场有何影响？
  • 日本女性保健市场以年龄层类型划分是怎样的？
  • 日本女性保健市场的应用基础如何细分？
  • 日本女性保健品市场在配销通路上的分化是怎么样的？
  • 日本女性保健市场价值链的各个阶段是什么？
  • 日本女性健康的关键驱动因素和挑战是什么？
  • 日本女性保健市场的结构如何？
  • 日本女性保健品市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：日本女性健康市集 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章：日本女性保健市场格局

  • 历史与当前市场趋势（2018-2023）
  • 市场预测（2024-2032）

第 6 章：日本女性保健市场 - 细分：按年龄组类型

  • 50岁以上
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场区隔
      • 停经后骨质疏鬆症
      • 子宫内膜异位症和子宫肌瘤
      • 停经
    • 市场预测（2024-2032）
  • 其他的
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 7 章：日本女性保健市场 - 细分：按应用分类

  • 避孕药具
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 骨质疏鬆症
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 停经
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 不孕症
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 其他的
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 8 章：日本女性保健市场 - 细分：按配销通路

  • 医院药房
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 零售药局
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 网路药局
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 9 章：日本女性保健市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 10 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本女性保健市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章：附录

简介目录
Product Code: SR112024A18343

Japan women's health market size reached US$ 2,419.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,278.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.4% during 2024-2032. The increasing advances in medical technology, such as robotic-assisted surgery, minimally invasive procedures, and telemedicine, which have improved the diagnosis and treatment options available for women's health conditions, are primarily driving the market.

Women's health refers to the unique physical, mental, and emotional well-being of women across their lifespan. It encompasses a wide range of issues, including reproductive health, sexual health, and overall physical fitness. Key aspects of women's health include menstrual and menopausal health, pregnancy and childbirth, contraception, breast health, and gynecological care. Regular check-ups, screenings, and access to healthcare are essential to maintaining women's health. This includes Pap smears, mammograms, and discussions about family planning. Mental health is also crucial, as women are more susceptible to conditions like depression and anxiety. A healthy lifestyle, including a balanced diet, regular exercise, and stress management, plays a significant role in women's health. Additionally, promoting gender equality and addressing societal factors that affect women's health, such as discrimination and unequal access to healthcare, are essential steps toward ensuring that women can lead healthy and fulfilling lives. Women's health is a multifaceted and critical aspect of public health, deserving attention and support.

Japan Women's Health Market Trends:

The women's health market in Japan is multifaceted and interconnected, driven by various factors that collectively shape the landscape of healthcare for women. Firstly, advances in medical research and technology have significantly propelled the women's health market forward. Breakthroughs in diagnostic tools, such as mammography and genetic testing, have enhanced the early detection of diseases like breast cancer and hereditary conditions, improving overall health outcomes. Secondly, the growing awareness of women's unique healthcare needs has played a pivotal role. Women are increasingly informed about the importance of preventive care, leading to higher demand for gynecological services, contraceptives, and maternity care. Furthermore, societal shifts, including delayed childbirth and an aging female population, have contributed to the expansion of this market. These shifts require tailored healthcare solutions, driving innovation and investment in women's health services. Moreover, various regulatory changes and government initiatives improve access to healthcare through several policies, thereby enhancing the affordability and availability of women's health services. This, in turn, is expected to drive the women's health market in Japan during the forecast period.

Japan Women's Health Market Segmentation:

Age Group Type Insights:

50 Years and Above

  • Postmenopausal Osteoporosis
  • Endometriosis and Uterine Fibroids
  • Menopause
  • Others

Application Insights:

  • Contraceptives
  • Osteoporosis
  • Menopause
  • Infertility
  • Others

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan women's health market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan women's health market?
  • What is the breakup of the Japan women's health market on the basis of age group type?
  • What is the breakup of the Japan women's health market on the basis of application?
  • What is the breakup of the Japan women's health market on the basis of distribution channel?
  • What are the various stages in the value chain of the Japan women's health market?
  • What are the key driving factors and challenges in the Japan women's health?
  • What is the structure of the Japan women's health market and who are the key players?
  • What is the degree of competition in the Japan women's health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Women's Health Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Women's Health Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Women's Health Market - Breakup by Age Group Type

  • 6.1 50 Years and Above
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Postmenopausal Osteoporosis
      • 6.1.3.2 Endometriosis and Uterine Fibroids
      • 6.1.3.3 Menopause
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Others
    • 6.2.1 Historical and Current Market Trends (2018-2023)
    • 6.2.2 Market Forecast (2024-2032)

7 Japan Women's Health Market - Breakup by Application

  • 7.1 Contraceptives
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Osteoporosis
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Menopause
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Infertility
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2018-2023)
    • 7.5.2 Market Forecast (2024-2032)

8 Japan Women's Health Market - Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Retail Pharmacies
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Online Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)

9 Japan Women's Health Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Women's Health Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix